首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Codon Usage Optimization and Construction of Plasmid Encoding Iranian Human Papillomavirus Type 16 E7 Oncogene for Lactococcus Lactis Subsp. Cremoris MG1363
【24h】

Codon Usage Optimization and Construction of Plasmid Encoding Iranian Human Papillomavirus Type 16 E7 Oncogene for Lactococcus Lactis Subsp. Cremoris MG1363

机译:乳酸乳球菌亚种伊朗人乳头瘤病毒16型E7癌基因的密码子使用优化和质粒构建。 cremoris MG1363

获取原文
           

摘要

HPV 16 intratypic sequence variations has been recognized in association with oncogenic potential diverge and geographic distribution. This study aimed to investigate nucleotide modifications and optimization of HPV 16 E7 regions from Iranian infected women. Cervical biopsies from 79/163 HPV 16 positive cancer patients detected in our study were analyzed by PCR in a couple of cloning of a complete ORF of the E7 gene, and sequencing. The most frequently observed variant was C196T in E7 which led to an amino acid change of R66W. In addition, only one common variant T234G was identified from all specimens, but it did not lead to any amino acid change. We also detected nucleotide variations A86G, and C188T in samples. Among 99 codons in E7 gene, 56 codons were improved for Lactococcus lactis subsp. cremoris MG1363 resulting in a reduced G+C content from 43.1% to 34.0%. Also, the AT%, ENC, and CAI values were 66, 20±1.1, and 1.000 instead of 56.90, 60 ±1.1, and 0.406 respectively. Finally we constructed expression vector pNZ8148 encoding optimized E7 oncoprotein of HPV 16. This study declared for the first time, the genetic variations of HPV 16 E7 in IRAN. We conclude that plasmid pNZ8148-HPV 16-opti E7 can be potential vaccine candidates in the future.
机译:HPV 16型内序列变异与致癌的潜在差异和地理分布有关。这项研究旨在调查伊朗感染妇女的HPV 16 E7区域的核苷酸修饰和优化。在两次克隆完整E7基因的ORF并进行测序的过程中,通过PCR分析了我们研究中检测到的79/163 HPV 16例阳性癌症患者的宫颈活检。最常见的变体是E7中的C196T,导致R66W的氨基酸变化。另外,从所有标本中仅鉴定出一种常见的变体T234G,但它没有导致任何氨基酸变化。我们还检测了样品中的核苷酸变异A86G和C188T。在E7基因的99个密码子中,乳酸乳球菌亚种改善了56个密码子。 cremoris MG1363可将G + C含量从43.1%降低至34.0%。另外,AT%,ENC和CAI值分别为66、20±1.1和1.000,而不是56.90、60±1.1和0.406。最后,我们构建了表达载体pNZ8148,该载体编码优化的HPV 16 E7癌蛋白。这项研究首次宣布了HPV 16 E7在伊朗的遗传变异。我们得出的结论是,质粒pNZ8148-HPV 16-opti E7将来可能成为潜在的疫苗候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号